Is there a threshold platelet count for which you would consider holding RT?

It depends on what site. For head and neck and thoracic malignancies contribution to marrow dose is minimal and myelosuppression is normal nadir effect of chemo so we dont hold RT for low platelets. For pelvic malignancies I usually use threshold of 50K for holding RT and 100K for holding concurrent...